Skip to content
MMJ Gazette
  Tuesday 5 August 2025
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
August 4, 2025Cannabis Businesses Face Tightrope Act as Rules Shift State to State August 3, 2025Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves August 2, 2025Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E August 2, 2025Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn July 31, 2025Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off July 30, 2025Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal July 30, 2025Starting a Cannabis Business? Here’s What You Really Need to Know First July 29, 2025New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle? July 29, 2025Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate July 28, 2025Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  Canopy Growth Faces Another Quarter of Losses Despite Revenue Growth
Cannabis

Canopy Growth Faces Another Quarter of Losses Despite Revenue Growth

Lars BeckersLars Beckers—February 10, 20240
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Canopy Growth Corporation, one of the leading cannabis producers in Canada, announced its financial results for the third quarter of fiscal 2024 on Tuesday. The company reported a net loss of $216.8 million, a slight improvement from the $264.4 million loss in the same period last year. However, the company also saw an increase in its net revenue, gross margins, and international sales, indicating some signs of progress in its turnaround strategy.

Canopy

Revenue Increases Across Business Units

Canopy Growth’s net revenue for the quarter ended December 31, 2023, was $78.5 million, after deducting $11.6 million in excise taxes. This represents a 6% increase from the $74.3 million in net revenue in the third quarter of fiscal 2023, excluding the impact of the sale of its Canadian national retail business. The company attributed the revenue growth to its diversified portfolio of cannabis products, including flowers, oils, edibles, vapes, and beverages.

The company’s Canada adult-use cannabis business-to-business net revenue rose 9% year-over-year, reaching $39 million. This was driven by higher sales volumes, an improved product mix, and increased market share. According to the company, it held the top three positions for cannabis flowers in the British Columbia market and re-established its Wana brand of cannabis gummies as a top seller in Ontario and British Columbia.

The company’s Canadian medical cannabis net revenue also increased 11% year-over-year, reaching $14.8 million. This was mainly due to higher sales volumes and higher average selling prices. The company said it continued to serve over 70,000 medical patients in Canada and launched new products such as CBD oil softgels and THC oil spray.

The company’s international cannabis net revenue grew 81% year-over-year, reaching $18.3 million. This was led by strong sales growth in the Australian and German markets, where the company’s medical cannabis products have been well received. The company said its Australian medical cannabis business has generated 12 straight quarters of revenue growth, and its German business has benefited from the launch of its Spectrum Therapeutics brand and the expansion of its distribution network.

The company’s other consumer products net revenue, which includes its vaporizer business Storz & Bickel, its bio-steel sports nutrition business, and its This Works skincare business, reached $24.1 million, up 54% from the previous quarter. The company said the growth was driven by strong sales of the new VENTY portable vaporizer and traditionally strong seasonal sales of its other consumer products.

Losses Narrow as Cost-Cutting Measures Take Effect

Canopy Growth’s net loss attributable to the company decreased to $216.8 million, or $2.62 per diluted share, from $264.4 million, or $5.34 per diluted share, in the third quarter of fiscal 2023. The company said the improvement was mainly due to lower operating expenses, lower share-based compensation expenses, and lower impairment and restructuring charges.

The company’s operating expenses decreased 23% year-over-year, reaching $139.8 million. The company said this was the result of its cost-cutting measures, which included reducing its headcount, closing some of its production facilities, and streamlining its organizational structure. The company also reduced its share-based compensation expenses by 67% year-over-year, reaching $37.1 million. The company said this was due to lower stock price volatility and lower stock option grants.

The company’s impairment and restructuring charges decreased 79% year-over-year, reaching $45.4 million. The company said this was mainly due to lower asset write-downs and lower contract termination costs. The company also reduced its overall debt by $69 million during the quarter and improved its free cash flow from continuing operations by 57% year-over-year, reaching $34 million.

The company’s gross margins increased to 28% in the third quarter of fiscal 2024, up from a negative 11% in the third quarter of fiscal 2023. The company said this was due to higher sales volumes, higher average selling prices, a lower cost of goods sold, and lower inventory provisions.

CEO Optimistic About Future Growth Opportunities

David Klein, the CEO of Canopy Growth, said in a press release that the company is entering a new era of growth and profitability. He said the company is focused on cannabis and demonstrating growth across all of its business units. He also said the company is moving forward with its Canopy USA strategy, which aims to enter the US cannabis market through a partnership with Acreage Holdings, a multi-state operator. The company said it expects to be the first and only US-listed company offering shareholders a unique opportunity to gain exposure to the fastest-growing cannabis market in the world.

“We are executing against our strategy and delivering results,” Klein said. “We have a clear path to profitability and positive cash flow, and we are making the necessary investments to position Canopy Growth for long-term leadership in the global cannabis industry.”

The company said it expects to achieve positive adjusted EBITDA in the second half of fiscal 2024 and positive free cash flow from operations in fiscal 2025. The company also said it expects to launch new products and brands in the coming quarters, including Martha Stewart CBD wellness gummies, Quatreau CBD-infused sparkling water, and Tokyo Smoke Go cannabis beverages.

The company also said it will hold a special meeting of shareholders on April 12, 2024, to seek approval for its proposed acquisition of Acreage Holdings, which is subject to the federal legalization of cannabis in the US. The company said it believes the acquisition will create significant value for both companies and their shareholders and will enable Canopy Growth to access the US cannabis market, which is estimated to be worth over $40 billion by 2025.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Alberta-based cannabis producer seeks buyer amid financial troubles
Hawaii Faces Three Different Paths to Cannabis Legalization
Related posts
  • Related posts
  • More from author
Cannabis

Cannabis Businesses Face Tightrope Act as Rules Shift State to State

August 4, 20250
Cannabis

Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves

August 3, 20250
Cannabis

Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off

July 31, 20250
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Cannabis Businesses Face Tightrope Act as Rules Shift State to State
  • Cannabis Dispensaries Rethink Retail: Design That Sells, Not Just Serves
  • Legal Weed’s Tax Nightmare: How Cannabis Firms Are Pushing Back Against 280E
  • Kentucky Gears Up for First Legal Medical Marijuana Sales by Autumn
  • Hemp THC Ban Pulled from Senate Bill After McConnell–Paul Face-Off
  • Oklahoma’s Marijuana Legalisation Fight Is Back—And It’s Getting Personal
  • Starting a Cannabis Business? Here’s What You Really Need to Know First
  • New York’s Legal Weed Market Nears $1.5 Billion, But How Many Shops Can It Really Handle?
  • Texas Lawmaker Pushes Cannabis Legalisation Bill During Heated Hemp Debate
  • Cannabis Shops Are Getting a Makeover – and Sales Are Going Up
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors